159 related articles for article (PubMed ID: 6083796)
21. Single or multiple injections of methamphetamine increased dopamine turnover but did not decrease tyrosine hydroxylase levels or cleave caspase-3 in caudate-putamen.
Pereira FC; Lourenço ES; Borges F; Morgadinho T; Ribeiro CF; Macedo TR; Ali SF
Synapse; 2006 Sep; 60(3):185-93. PubMed ID: 16739116
[TBL] [Abstract][Full Text] [Related]
22. Lisuride- and D-LSD-induced changes of monoamine turnover in the rat brain.
Keller HH; Burkard WP; Pieri L; Bonetti EP; Da Prada M
Adv Biochem Psychopharmacol; 1978; 19():393-6. PubMed ID: 696467
[No Abstract] [Full Text] [Related]
23. Influence of aging and social isolation on changes in brain monoamine turnover and biosynthesis of rats elicited by novelty stress.
Miura H; Qiao H; Ohta T
Synapse; 2002 Nov; 46(2):116-24. PubMed ID: 12211090
[TBL] [Abstract][Full Text] [Related]
24. The effect of methiothepin on cerebral monoamine neurons.
Lloyd KG; Bartholini G
Adv Biochem Psychopharmacol; 1974; 10():305-9. PubMed ID: 4846546
[No Abstract] [Full Text] [Related]
25. Simultaneous determination of DA, NA, 5HT and their metabolites in several rat brain areas by HPLC with electrochemical detection.
Achilli G; Perego C; Ponzio F; Algeri S
Res Commun Chem Pathol Pharmacol; 1983 Apr; 40(1):67-72. PubMed ID: 6191373
[TBL] [Abstract][Full Text] [Related]
26. The effects of subhypnotic doses of ethanol on regional catecholamine turnover.
Bacopoulos NG; Bhatnagar RK; Van Orden LS
J Pharmacol Exp Ther; 1978 Jan; 204(1):1-10. PubMed ID: 619123
[TBL] [Abstract][Full Text] [Related]
27. Time-related changes in serum perphenazine, striatal 3H-spiperone binding and regional brain acid metabolites of dopamine and 5-hydroxy-tryptamine after a single dose of perphenazine.
Mjörndal T; Persson SA
Fundam Clin Pharmacol; 1990; 4(2):213-22. PubMed ID: 1693589
[TBL] [Abstract][Full Text] [Related]
28. Effects of mazindol, a non-phenylethylamine anorexigenic agent, on biogenic amine levels and turnover rate.
Carruba MO; Groppetti A; Mantegazza P; Vicentini L; Zambotti F
Br J Pharmacol; 1976 Apr; 56(4):431-6. PubMed ID: 1260223
[TBL] [Abstract][Full Text] [Related]
29. Decreased raphe serotonin in rabbits with experimental herpes simplex encephalitis.
Päivärinta MA; Marttila RJ; Lönnberg P; Rinne UK
Neurosci Lett; 1993 Jun; 156(1-2):1-4. PubMed ID: 7692357
[TBL] [Abstract][Full Text] [Related]
30. Regional differences in chronic neuroleptic effects on extracellular dopamine activity.
See RE; Chapman MA; Murray CE; Aravagiri M
Brain Res Bull; 1992; 29(3-4):473-8. PubMed ID: 1382815
[TBL] [Abstract][Full Text] [Related]
31. Altered monamine metabolism in caudate-putamen of iron-deficient rats.
Beard JL; Chen Q; Connor J; Jones BC
Pharmacol Biochem Behav; 1994 Jul; 48(3):621-4. PubMed ID: 7524105
[TBL] [Abstract][Full Text] [Related]
32. Role of the dopaminergic system in the cataleptogenic action of bulbocapnine.
Massotti M; Longo VG
J Pharm Pharmacol; 1979 Oct; 31(10):691-5. PubMed ID: 41042
[TBL] [Abstract][Full Text] [Related]
33. Prenatal effects of acute harmaline exposure on fetal brain biogenic amine metabolism.
Okonmah AD; Brown JW; Blyden GT; Soliman KF
Pharmacology; 1988; 37(3):203-8. PubMed ID: 2465555
[TBL] [Abstract][Full Text] [Related]
34. Chronic treatment with SCH 23390, a selective dopamine D-1 receptor antagonist, decreases dopamine metabolism in rat caudate nucleus.
Koulu M; Lappalainen J; Pesonen U; Hietala J; Syvälahti E
Eur J Pharmacol; 1988 Oct; 155(3):313-6. PubMed ID: 3069483
[TBL] [Abstract][Full Text] [Related]
35. The effects of desipramine, zimelidine, electroconvulsive treatment and lithium on rat brain biogenic amines: a comparison with peripheral changes.
Karoum F; Korpi ER; Chuang LW; Linnoila M; Wyatt RJ
Eur J Pharmacol; 1986 Mar; 121(3):377-85. PubMed ID: 2422047
[TBL] [Abstract][Full Text] [Related]
36. Substituted ergolines: potential antipsychotics with unique profile. II. Neurochemical characterization.
Auth F; Kiss B; Laszlovszky I; Lapis E
Pol J Pharmacol Pharm; 1988; 40(6):603-11. PubMed ID: 2479935
[TBL] [Abstract][Full Text] [Related]
37. Reduced haloperidol: effects on striatal dopamine metabolism and conversion to haloperidol in the rat.
Korpi ER; Wyatt RJ
Psychopharmacology (Berl); 1984; 83(1):34-7. PubMed ID: 6204352
[TBL] [Abstract][Full Text] [Related]
38. Brain catecholamines, serotonin and their metabolites in mice selected for low (MGL) and high (MGH) blood magnesium levels.
Amyard N; Leyris A; Monier C; Francès H; Boulu RG; Henrotte JG
Magnes Res; 1995 Mar; 8(1):5-9. PubMed ID: 7545412
[TBL] [Abstract][Full Text] [Related]
39. Serotonin and dopamine turnover after acute and chronic morphine administration.
Papeschi R; Theiss P; Herz A
Arzneimittelforschung; 1974 Jul; 24(7):1017-9. PubMed ID: 4408355
[No Abstract] [Full Text] [Related]
40. Effects of 5-(n-butyl)-picolinamide (SCH 10595), a dopamine-beta-hydroxylase inhibitor, on serotonin and catecholamine metabolites in brain.
Korduba CA; Veals J; Symchowicz S
J Pharmacol Exp Ther; 1974 Sep; 190(3):459-65. PubMed ID: 4413186
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
